Adalimumab Concentration Changes After Dose Escalation in Inflammatory Bowel Disease

Background: Dose escalation of adalimumab (ADA) for loss or response in inflammatory bowel disease (IBD) is a common practice. Recent data suggest improved outcomes with an ADA concentration of 12 mcg/mL, but limited data are available on the ability to achieve a target concentration. The aim of this study was to determine the expected change in serum ADA concentration after a dose escalation performed every 7 days in patients with IBD. Methods: A retrospective cohort of patients with IBD receiving ADA was divided into every fourteen-day dosing, every 7-day dosing, and dose escalation (ie, q14 to q7 day dosing). The primary outcome was the change in ADA concentration. Multiple logistic regression was performed to identify predictors of achieving a target ADA concentration of ≥12 mcg/mL. Results: Overall, 380 patients were identified, of whom 200 underwent dose escalation, 100 remained on q14 days dosing, and 80 were maintained on q7 day dosing. After dose escalation, the mean ADA concentration increased by 5.5 mcg/mL (P
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Original Article Source Type: research

Related Links:

This study examines a subset of patients whose course was complicated by rectal stump leaks after initial subtotal colectomy.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Colon and Rectal Surgery Source Type: research
Inflammatory bowel disease (IBD) patients are challenging to manage perioperatively due to disease complexity and multiple comorbidities. This retrospective multicenter database study aims to assess factors associated with extended length of stay in post-surgical IBD patients.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Colon and Rectal Surgery Source Type: research
Crohn ’s disease (CD) is a chronic, relapsing, inflammatory bowel disease which can affect any area of the gastrointestinal tract and may require intestinal resection with anastomosis or ostomy creation (OC). However, the morbidity of OC in pediatric patients with CD is unknown.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Pediatric Surgery Source Type: research
Mesenchymal stem cells (MSCs), which exert regulatory effects on various immune cells, have been a promising therapy for inflammatory bowel disease treatment. However, their therapeutic effects are limited by lack of nutritional supply, immune system attack, and low accumulation on the target site. Here, inspired by the natural incubation mechanism...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Engineering Physical Sciences Source Type: research
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Source Type: research
This study aimed to establish the role of real-time AI in stratifying the relapse risk of patients with UC in clinical remission.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Source Type: research
Contributors : Evgeny Knyazev ; Stepan NersisyanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensIntestinal epithelial cells exist in physiological hypoxia, leading to hypoxia-inducible factor (HIF) activation and supporting barrier function and cell metabolism of the intestinal epithelium. In contrast, pathological hypoxia is a common feature of some disorders, including inflammatory bowel disease (IBD). This work was aimed at studying HIF-associated changes in the intestinal epithelium in IBD. In the first step, a list of genes responding to chemical activation of hypoxia was obtaine...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Homo sapiens Source Type: research
Conclusion: The misleading term “cytokine storm” implies increased blood levels of cytokines are responsible for a grave clinical condition. Not all inflammatory conditions resulting in worsened disease states are correlated with significantly elevated cytokine levels, despite an association with the term “cytokine storm”. “Cytokine storm” should be removed from the medical lexicon since it does not reflect the mediators driving the disease nor does it predict which diseases will respond to cytokine inhibitors.
Source: Shock - Category: Emergency Medicine Tags: Review Articles Source Type: research
Evid Based Complement Alternat Med. 2021 Oct 11;2021:5416487. doi: 10.1155/2021/5416487. eCollection 2021.ABSTRACTIn recent years, the incidence of Crohn's disease (CD) in the Asia-Pacific region is gradually increasing, and the onset age is decreased at the same time. The relapse of illness and long course of disease easily lead to malnutrition, which will affect the treatment effect of the disease and even worsen the disease. Therefore, it is very important to find the risk factors affecting the nutritional status of children with CD and to carry out effective nursing intervention accordingly. In our study, a total of 18...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Source Type: research
Gut Liver. 2021 Oct 21. doi: 10.5009/gnl210262. Online ahead of print.ABSTRACTDuring the past decade, we have entered an era of biologics for the treatment of Crohn's disease and ulcerative colitis. The therapeutic goal of inflammatory bowel disease (IBD) management has evolved from symptom control and clinical remission to mucosal healing or even deep remission. Histological remission for ulcerative colitis and transmural healing of Crohn's disease are potential future goals. With the adoption of the treat-to-target concept, and given the need for tight control of IBD activity, therapeutic drug monitoring (TDM) is an impo...
Source: Gut and Liver - Category: Gastroenterology Authors: Source Type: research
More News: Drugs & Pharmacology | Humira | Inflammatory Bowel Disease | Study